XML 37 R24.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Business Segments and Other Information
 12 Months Ended
Dec. 31, 2010
Business Segments and Other Information [Abstract]  
Business segments and other information
Note 16 — Business segments and other information
An operating segment is a component of an enterprise (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the enterprise’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. Based on these criteria, the Company has determined that it has two operating segments: Medical and Aerospace.
The Medical Segment businesses design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care. Additionally, the company designs, manufactures and supplies devices and instruments for other medical device manufacturers. Over 90 percent of Medical Segment net revenues are derived from devices that are considered disposable or single use. The Medical Segment’s products are largely sold and distributed to hospitals and healthcare providers and are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications.
The Aerospace Segment businesses provide cargo handling systems for wide body and narrow body aircraft. Commercial aviation markets represent all of the revenues in this segment. Markets for these products are generally influenced by spending patterns in the commercial aviation markets and cargo market trends.
Information about continuing operations by business segment is as follows:
                         
    2010     2009     2008  
    (Dollars in thousands)  
Segment data:
                       
Medical
  $ 1,433,282     $ 1,434,885     $ 1,475,621  
Aerospace
    128,037       124,463       149,452  
 
                 
Net revenues
  $ 1,561,319     $ 1,559,348     $ 1,625,073  
 
                 
Medical
  $ 276,145     $ 302,607     $ 282,997  
Aerospace
    22,920       13,817       16,244  
 
                 
Segment operating profit(1)
    299,065       316,424       299,241  
Corporate expenses
    41,729       43,193       49,001  
Restructuring and other impairment charges
    2,875       10,347       24,946  
Net (gain) loss on sales of businesses and assets
    (341 )     —       (296 )
Noncontrolling interest
    (1,361 )     (1,157 )     (747 )
 
                 
Income from continuing operations before interest, loss on extinguishments of debt and taxes
  $ 256,163     $ 264,041     $ 226,337  
 
                 
Identifiable assets(2):
                       
Medical
  $ 3,069,875     $ 3,135,349     $ 3,135,360  
Aerospace
    98,878       120,277       244,994  
Commercial
    92,962       111,209       215,894  
Corporate(3)
    373,481       463,304       322,286  
 
                 
 
  $ 3,635,196     $ 3,830,139     $ 3,918,534  
 
                 
Capital expenditures:
                       
Medical
  $ 28,618     $ 24,947     $ 23,054  
Aerospace
    1,575       1,601       2,519  
Corporate
    1,423       1,394       1,496  
 
                 
 
  $ 31,616     $ 27,942     $ 27,069  
 
                 
Depreciation and amortization expense:
                       
Medical
  $ 82,820     $ 86,854     $ 88,923  
Aerospace
    1,996       1,886       1,831  
Corporate
    10,578       9,337       8,499  
 
                 
 
  $ 95,394     $ 98,077     $ 99,253  
 
                 
(1)   Segment operating profit includes a segment’s net revenues reduced by its cost of goods sold along with the segment’s selling, general and administrative expenses and noncontrolling interest. Unallocated corporate expenses, (gain) loss on sales of businesses and assets, restructuring and impairment charges, interest income and expense and taxes on income are excluded from the measure.
 
(2)   Identifiable assets do not include assets held for sale of $8.0 million, $8.9 million and $8.2 million in 2010, 2009 and 2008, respectively.
 
(3)   Identifiable corporate assets include cash, receivables acquired from operating segments for securitization, investments in unconsolidated entities, property, plant and equipment and deferred tax assets primarily related to net operating losses and pension and retiree medical plans.
Information about continuing operations in different geographic areas is as follows:
                         
    2010     2009     2008  
    (Dollars in thousands)  
Net revenues (based on business unit location):
                       
United States
  $ 785,343     $ 791,127     $ 829,547  
Other Americas
    49,557       46,289       49,133  
Germany
    221,915       238,229       300,672  
Other Europe
    384,592       381,687       361,894  
All Other
    119,912       102,016       83,827  
 
                 
 
  $ 1,561,319     $ 1,559,348     $ 1,625,073  
 
                 
Net property, plant and equipment:
                       
United States
  $ 165,287     $ 187,880     $ 198,689  
Other Americas
    25,988       26,587       38,971  
Germany
    19,630       21,924       24,855  
Other Europe
    55,848       61,533       67,700  
All Other
    20,952       19,575       44,077  
 
                 
 
  $ 287,705     $ 317,499     $ 374,292